| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.43 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |